PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D825F39YH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $83,652
Award facts
- Contract value 100% obligated
- $83,652.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, issued on August 15, 2025, awards AmerisourceBergen Drug Corp a firm fixed-price contract valued at $83,652.14 for pharmaceutical and medical supply provision. The contract is a child award under the company's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The work is to be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation to the DLA Medical Supply Chain, a defense agency program, and reflects AmerisourceBergen's established role as a critical pharmaceutical distributor for federal military and veteran healthcare systems.
AmerisourceBergen Drug Corp supplies a comprehensive portfolio of pharmaceutical products and medical commodities to support military healthcare operations globally, including brand-name and generic medications, vaccines, specialty drugs, and medical devices across multiple therapeutic categories. The parent IDC serves as a flexible contracting vehicle enabling the company to fulfill pharmaceutical needs for multiple federal customers, including the Defense Health Agency and U.S. Coast Guard. The DLA is pursuing a strategic multi-award approach through its planned Pharmaceutical Prime Vendor Global Program Generation V contracts, intended to distribute regional pharmaceutical support among multiple contractors, positioning AmerisourceBergen as one of several key vendors supporting the department's medical supply chain operations.
Quick answers
Who was awarded contract SPE2D825F39YH?
SPE2D825F39YH was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 15, 2025.
How much is contract SPE2D825F39YH worth?
The government has obligated $83,652 on SPE2D825F39YH.
Is contract SPE2D825F39YH an order under another contract?
Yes. SPE2D825F39YH is a delivery order under SPE2DX22D0020, an indefinite delivery contract.
Was contract SPE2D825F39YH competed?
The extent of competition for SPE2D825F39YH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award